Three publications over the holiday period:

• A standardised measurement and valuation scale of genomic utility for policy decisions: the GUV-scale | link
• Exome Sequencing in the Diagnostic Pathway for Suspected Rare Genetic Diseases: Does the Order of Testing Affect its Cost-Effectiveness? | link
• A cost-effective two-step approach for multi-cancer early detection in high-risk populations | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.